Publication:
Alpha-7 nicotinic receptor agonist GTS-21 ameliorates contrast-induced nephropathy in rats

dc.contributor.authorAKÇAY, SEÇKİN
dc.contributor.authorÖZDEMİR KUMRAL, ZARİFE NİGAR
dc.contributor.authorPEKER EYÜBOĞLU, İREM
dc.contributor.authorYEGEN, BERRAK
dc.contributor.authorsAKÇAY S., ÖZDEMİR KUMRAL Z. N., çilingir kaya ö. T., PEKER EYÜBOĞLU İ., AKKİPRİK M., YEGEN B.
dc.date.accessioned2023-06-21T08:25:47Z
dc.date.accessioned2026-01-11T15:52:34Z
dc.date.available2023-06-21T08:25:47Z
dc.date.issued2019-10-05
dc.identifier.citationAKÇAY S., ÖZDEMİR KUMRAL Z. N., çilingir kaya ö. T., PEKER EYÜBOĞLU İ., AKKİPRİK M., YEGEN B., \"Alpha-7 Nicotinic Receptor Agonist GTS-21 Ameliorates Contrast-Induced Nephropathy in Rats\", JASN, 5 - 10 Kasım 2019
dc.identifier.urihttps://hdl.handle.net/11424/290485
dc.language.isoeng
dc.relation.ispartofJASN
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleAlpha-7 nicotinic receptor agonist GTS-21 ameliorates contrast-induced nephropathy in rats
dc.typeconferenceObject
dspace.entity.typePublication

Files